International Journal Of Modern
Pharmaceutical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Science & Pharmacy Professional

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

INTERNATIONAL JOURNAL OF MODERN PHARMACEUTICAL RESEARCH has been indexed and abstracted by various international reputed agencies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , Web of Science Group (Under Process) , IFSIJ Measure of Journal Quality , Research Publication Rating and Indexing , IP Indexing (IP Value 2.42) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing (ISI) , Scope Database , ABCD Index , Academia , International Scientific Indexing, UAE (ISI) , ISSN National Centre , DOI-Digital Online Identifier , Zenodo Indexing , International CODEN Service, USA  and many more.
ISSN 2319-5878
IMPACT FACTOR: 7.533

Abstract

HYPERTENSIVE MEDICATIONS ON QUALITY OF LIFE IN HYPERTENSIVE PATIENTS A COMPARATIVE ASSESSMENT

Syed Azharullah Quadri*, Pawan Kumar, Mohammed Zubair Ahmed, Syed Fayyazuddin, Md. Ismail Zubair, Mohd Ateeq Ur Rehman, Mohammed Majid Iqbal

ABSTRACT

The key impartial to survey the quality of life in Hypertension patients and its associated factors among hypertensive patients. A cross-sectional education was carried out from September 2024 to March 2025 to investigate hypertensive patients’ treatment who are visiting Hospital with an antihypertensive prescription were enrolled for the study. A total of 500 patients were included in this education, among which 273 were male 54.6% & 227, 45.4% were female. In 500 patients, 121 patients were treated with monotherapy. In that 45.82% of patients were treated with Atenolol, 61.11% of patients were treated with losartan. In combination therapy most commonly used was double therapy 43.20% followed by triple therapy 15.80%. The first choice is Beta blocker 69.40% followed by Calcium Channel Blockers 59.60% was most prescribed class of drug followed by Angiotensin Receptor Blockers. In our study the final conclusion of the study reveals that Beta blocker as most prescribed class of antihypertensive and Atenolol was the most prescribed antihypertensive. In our study, most of the patients were treated with combination therapy in that double drug therapy was most common. There is a chance of various medication errors, development of adverse drug reaction as the 138 of patients belong to age above 60 years and chances of getting error also increases as combination therapy is most used. Therefore, close monitoring is required for such patients. During our discussion with patients we suggested for Lifestyle changes, it can help lower high blood pressure. Include, eating a healthy, low-salt diet, losing weight, being physically active and quitting tobacco & Alcohol.

[Full Text Article] [Certificate Download]

Indexing

News

  • Call for Paper

    IJMPR  Invited to submit your valuable manuscripts for Coming Issue.

  • NEW ISSUE PUBLISHED

    Its Our pleasure to inform you that, IJMPR 1 March 2026 Issue has been Published, Kindly check it on https://ijmpronline.com/current-issues

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • IJMPR: New Impact Factor

    IJMPR Impact Factor has been Increased from 6.669 to 7.533  for Year 2026.

  • IJMPR: MARCH ISSUE PUBLISHED

    MARCH 2026 Issue has been successfully launched IJMPR on 1 MARCH 2026.

Best Article Awards

IJMPR is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Powered By IJMPR | All Right Reserved

IJMPR